APOC3 and coronary artery disorder: Assuming this standard deviation in our study, each 1 mg/dL decrease in remnant cholesterol through lifelong genetically predicted APOC3 inhibition was associated with a 5% lower odds of CAD (OR, 0.95; 95% CI = 0.94–0.96, P = 4.3e-17).